Consider testing all therapy-naive patients for resistance in HIV

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Fosamprenavir: A Review of its Use in the Management of Antiretroviral Therapy-Naive Patients with HIV Infection

By Therese M. Chapman   Greg L. Plosker   Caroline M. Perry  

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2101-2124

Adis International

Access to resources Recommend Favorite

HIV tropism and its relationship with transmitted resistance in naive patients

By Sterrantino Gaetana   Zaccarelli Mauro   Di Giambenedetto Simona   De Luca Andrea   Francisci Daniela   Punzi Grazia   Monno Laura   Bruzzone Bianca   Antinori Andrea   Zazzi Maurizio  

Future Virology, Vol. 8, Iss. 8, 2013-08 ,pp. : 815-820

Future Medicine

Access to resources Recommend Favorite

Nevirapine-based HAART is more effective than protease inhibitor (PI)-based HAART in antiretroviral therapy-naive pregnant women with HIV infection

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection

By Re M.C.   Monari P.   Bon I.   Borderi M.   Chiodo F.   HIV-1 Emilia Romagna Infectious Disease Study Group  

International Journal of Antimicrobial Agents, Vol. 23, Iss. 2, 2004-02 ,pp. : 164-168

Elsevier

Access to resources Recommend Favorite